Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000694601 | SCV000823052 | likely benign | Nemaline myopathy 2 | 2023-12-14 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV005384821 | SCV006035091 | uncertain significance | Inborn genetic diseases | 2025-01-23 | criteria provided, single submitter | clinical testing | The c.16756C>G (p.R5586G) alteration is located in exon 121 (coding exon 119) of the NEB gene. This alteration results from a C to G substitution at nucleotide position 16756, causing the arginine (R) at amino acid position 5586 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
| Natera, |
RCV000694601 | SCV002084053 | uncertain significance | Nemaline myopathy 2 | 2019-11-11 | no assertion criteria provided | clinical testing |